State Street’s Intelligent Bio Solutions INBS Stock Holding History

State Street’s Portfolio INBS Stock Details INBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14	Closed	-$6.82K	–	4801
2022 Q4	$6.82K	Hold	14	–	–	﹤0.01%	4821
2022 Q3	$14K	Hold	14	–	–	﹤0.01%	4869
2022 Q2	$23K	Buy	14 +10	+250%	+$16.9K	﹤0.01%	4858
2022 Q1	$8K	Buy	+4	New	+$9.2K	﹤0.01%	4908

Other funds holding INBS

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street's INBS Position: Q1 2023 in Review

State Street sold out of Intelligent Bio Solutions (INBS) in Q1 2023, closing a stake of 14 shares — an estimated $6.82K sold.

State Street first reported a position in INBS in Q1 2022 and held it in 4 quarters. The position peaked at $23K in Q2 2022. 4 funds tracked by Wall St. Rank hold INBS as of Q1 2023.

State Street reported no remaining Intelligent Bio Solutions position as of Q1 2023 after selling out during the quarter.
State Street sold 14 Intelligent Bio Solutions shares in Q1 2023, an estimated $6.82K.
State Street first reported a position in Intelligent Bio Solutions in Q1 2022 and held it in 4 quarters.
State Street's Intelligent Bio Solutions position peaked at $23K in Q2 2022.
4 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q1 2023.

Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.